Skip to content
GLP-1 claims indirect or absentPeer-reviewed RCTs

Thorne Berberine review

Dozens of real RCTs exist for berberine — and meta-analyses disagree about whether they add up to meaningful weight loss

Reviewed August 26, 2026 · Visit thorne.com

What this is: a dietary supplement — not an FDA-approved medicine. It has not been evaluated by the FDA for safety, efficacy or quality, and nothing in this review is medical advice or an endorsement. If you are considering stopping or replacing prescribed medication with any product on this page, talk to your clinician first.

Overview

What Thorne Berberine is

Berberine earned the 'nature's Ozempic' nickname largely without its manufacturers asking for it: Thorne's own page makes no GLP-1 claim whatsoever, marketing the compound for heart, metabolic and GI support. The underlying research base is the deepest in this category — systematic reviews pooling twelve-plus randomized trials — but it points two directions at once. One 2020 meta-analysis finds about 2 kg of additional weight loss versus control; another the same year finds no significant effect. A 2026 JAMA Network Open trial examined liver-fat endpoints in MASLD. Against that contested backdrop, Thorne distinguishes itself on labelling discipline: quantified doses, explicit CYP enzyme interaction warnings, NSF Certified for Sport participation — the cleanest disclosure practices we reviewed.

Active ingredients

Thorne Berberine active ingredients as published
IngredientPublished dose
Berberine HCl (Indian Barberry root extract)450 mg per 2-capsule serving
Berberine Phytosome550 mg per 2-capsule serving

Best for

Statistically literate buyers curious about berberine's metabolic-marker literature, ideally alongside clinician oversight given its interaction profile.

Limitations

Anyone arriving via 'nature's Ozempic' headlines will not find that product here. Thorne sells a well-labelled botanical with contested weight-loss evidence and real drug interactions — the nickname did not come with the data.

Evidence rating

Peer-reviewed RCTs

Randomized, controlled human trials exist for this ingredient. Read the notes — trial design and sample size matter.

Claims vs evidence

What the brand says, and what we could verify

The company's mechanism claim is quoted or closely paraphrased from its own site. Of 4 cited studies, we could independently confirm 4 in indexed literature.

The claim

Thorne claims metabolic and cardiovascular support, stating studies show berberine 'can be effective in helping maintain a healthy body weight' and helps decrease abdominal fat and waist-to-hip ratio. It claims nothing about GLP-1 anywhere on the product page.

The evidence

Berberine is one of the most-trialled supplements in metabolism: Asbaghi 2020 (Clin Nutr ESPEN) pooled 12 RCTs and reported ~2.07 kg weighted mean additional weight loss; Xiong 2020 (Complement Ther Clin Pract) found no significant body-weight change across doses; Elahi Vahid 2026 updated the systematic-review record in Int J Obes; Lei 2026 ran the BRAVO randomized trial in JAMA Netw Open on liver fat in MASLD/obesity. Honest summary: dozens of small trials, conflicting pooled estimates, realistic effect around one to two kilograms — metabolic-marker evidence outruns weight-loss evidence.

Thorne Berberine cited studies and verification status
Cited studyReported findingIndependently verified
Asbaghi et al., Clin Nutr ESPEN 2020 (meta-analysis, 12 RCTs)Body weight WMD −2.07 kg vs controlConfirmed on PubMed
Xiong et al., Complement Ther Clin Pract 2020 (dose-response MA)No significant body-weight change (−0.11 kg)Confirmed on PubMed
Elahi Vahid et al., Int J Obes 2026 (SR/MA)Updated pooled analysis of berberine and adiposity outcomesConfirmed on PubMed
Lei et al., JAMA Netw Open 2026 (BRAVO RCT)Randomized trial of berberine in MASLD/obesity examining visceral adipose and liver-fat endpointsConfirmed on PubMed

Facts

Regulation, testing, dosing and price

Every figure is published by the brand. Where something is not disclosed, we say so rather than estimating.

Regulatory status
Dietary supplement with the standard FDA structure/function disclaimer. Berberine is a known inhibitor of CYP2D6, CYP2C9 and CYP3A4 — meaningfully drug-interactive for an OTC product.
Third-party testing
  • Stated third-party testing verifying label contents and contaminant limits
  • NSF Certified for Sport programme (site-wide; product-level listing not directly confirmed on the JS-rendered page)
How it's taken
One to two capsules twice daily with food — up to roughly 2,000 mg berberine daily at maximum labelled use.
Safety disclosures
Label warns against use in pregnancy, nursing or when trying to conceive, flags CYP2D6/CYP2C9/CYP3A4 inhibition (drug-interaction relevance), cautions about peanut/legume cross-allergy, and contraindicates hypersensitivity.
Manufacturer
Thorne HealthTech
Subscription
Save up to 20% on subscription
Guarantee
Not disclosed on the brand's site
Price as published
  • 60 capsules (30 servings)$44.00

Assessment

Pros and cons

Editorial judgment applied to the published facts above.

Pros

  • Deepest trial literature of any ingredient in this category — including JAMA-published work
  • No GLP-1 opportunism: Thorne lets the compound stand on its actual claims
  • Explicit, quantified drug-interaction warnings almost nowhere else in the supplement aisle
  • $44/month undercuts everything else reviewed here

Cons

  • Meta-analyses directly conflict on whether berberine produces significant weight loss
  • Realistic effect (~1–2 kg) is an order of magnitude below prescription GLP-1s
  • Product-page weight claims lean on the favourable meta-analysis
  • Guarantee terms are not published accessibly

Alternatives

If Thorne Berberine isn't what you're after

Pendulum Akkermansia

A scientifically serious probiotic strain with published RCTs behind the organism — and consumer surveys where you'd want product trials

Peer-reviewed RCTs

Calocurb

The strongest evidence base in this category — real peer-reviewed human trials, attached to marketing that still outruns them

Peer-reviewed RCTs

Thorne Berberine: frequently asked questions

Is berberine really 'nature's Ozempic'?
No. Berberine affects metabolism through AMPK activation and other pathways, not GLP-1 receptor agonism. Pooled trial data suggests around one to two kilograms of effect at best, with meta-analyses disagreeing — versus double-digit percentage body-weight changes in GLP-1 trials.
Does Thorne market its berberine for GLP-1?
No. Thorne's product page makes no GLP-1 claim; it positions the ingredient for heart, metabolic and GI support. The Ozempic comparison originates in media and social coverage, not the manufacturer.
What are the main risks of taking berberine?
Thorne's own label flags CYP2D6, CYP2C9 and CYP3A4 inhibition — berberine can change how your body processes other medications — and advises against use during pregnancy, nursing or conception attempts. Review it with a pharmacist or physician if you take anything else.

Sources

Verified August 26, 2026. Supplement formulations and prices change frequently — confirm current details with the brand.

Medical disclaimer

This review is editorial research about a commercial service. It is not medical advice, and it is not a recommendation to start, stop or change any treatment. GLP-1 medications are prescription drugs with real contraindications and side effects. Decisions about whether they are appropriate for you belong with a qualified clinician who knows your medical history. Prices and terms in this category change frequently — we publish the date each review was verified and link every source, but you should confirm current details with the provider before purchasing.